News

The project includes the discovery of new drugs that target immunomodulatory pathways involved in cancer and infectious diseases. In the project, ZoBio’s proprietary fragment screening technology, TINS, will

The drug falls in the cardiovascular segment and the combined sales of all the strengths as per NDC was estimated at $301 million in 2007. This marks the

The approval is said to help Elekta deliver and install this advanced technology at new and existing customer sites in Japan. According to the company, Leksell Gamma Knife

Under the terms of the agreement, Emergent will acquire substantially all assets of Protein Sciences (PSC), including: FluBlok (trivalent recombinant hemagglutinin vaccine). FluBlok is a Phase III influenza

Based on the collective labor agreement signed on May 8, 2008 with its social partners, a total of 24 labor contracts will be terminated in a first phase

The study will evaluate DM-83s effectiveness at controlling blood sugar levels in type 2 diabetics after consuming a meal. The 20 patient trial will measure both changes in

Under the agreement, GVK Bio will receive an initial payment and will be eligible for success-based milestone payments. GVK Bio will be responsible for identifying drug candidates, which

The GSL-120 – which has already been shipped and installed at various customer locations – is said to be specifically designed for integration with the Applied Imaging CytoVision

The key objective of the study is to assess the clinical efficacy of an oral capsule formulation of iclaprim as step-down therapy in comparison with a full course